Skip to main content
ConductScienceScienceDex

Jose M Mejia Oneto

NIH Rank #2463
Unclaimed recordClaim profile
  • Early Career

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 11763079Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2025Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.

NIH Funding · FY2024

Linked Award Amount
$3.1M
Full award amounts, FY2024
Award Records
3
Records listing this PI
Award-Linked Rank
#2,463
By linked amount among FY2024 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Jose M Mejia Oneto. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2024 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2024 award records by amount

NIH award records listing Jose M Mejia Oneto as a PI. Multi-PI records show the full award amount for context.

  • 1R44CA291345-01A1R44
    Antigen-targeted activation of Topo1 inhibitors via click chemistry
    Shasqi, Inc.
    $1.6M
    award amount
  • 5R44CA285160-02R44
    Antibody-guided localized activation of bioorthogonal protodrugs via click chemistry
    Shasqi, Inc.
    $1.2M
    award amount
  • 5R44CA265665-03R44
    Assessing the safety and efficacy of SQ3370 in a phase 1b dose-expansion cohort at the recommended Phase 2 dose in patients with advanced sarcoma
    Shasqi, Inc.
    $322.1K
    award amount

Award organization

Organizations that administered FY2024 awards listing Jose M Mejia Oneto as a PI.

FY2024 award administered by Shasqi, Inc. (CA).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    Shasqi, Inc.
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    Entered Top 50% Nationally
    Ranked #2463
  6. 2024
    Entered Top 25% Nationally
    Ranked #2463

Shared-award investigators

Other investigators listed on at least one of the same NIH award records as Jose M Mejia Oneto.

Jesse Mischa McFarland
Shasqi, Inc.
4
shared awards

Explore further

Find collaborators for Jose M Mejia Oneto

Search NIH-funded principal investigators by topic, department, or activity.

Open Find Collaborators →

Benchmark grant budgets

Compare median NIH grant budgets across departments, mechanisms, and years.

Open Grant Budget Benchmark →